Travis Parke Schrank

The paper develops GARD, a pipeline using genomic data and large language models to identify drug repurposing candidates for head and neck cancer, finding both known and emerging therapeutic options.

This study identifies molecular traits distinguishing HPV+ oropharyngeal cancer recurrence, showing reduced genomic instability contributes to tumor progression and immune suppression.